Stéphane Bernad

Title: Stéphane Bernad: Innovator in Pharmaceutical Chemistry

Introduction

Stéphane Bernad is a notable inventor based in La Varenne Saint-Hilaire, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on tenatoprazole potassium salts. His research has the potential to impact the development of new pharmaceutical compositions.

Latest Patents

Stéphane holds a patent for "Conglomerates of tenatoprazole potassium salts." This invention relates to conglomerates of tenatoprazole potassium salts that consist of an equimolar mixture of enantiomers with R and S configurations. These salts are capable of crystallization in the form of a conglomerate and include tenatoprazole dehydrated potassium salt, tenatoprazole potassium dimethanolate, tenatoprazole potassium diethanolate, and tenatoprazole potassium ethylene-glycolate. The patent also covers a pharmaceutical composition containing such salts and their various uses.

Career Highlights

Stéphane Bernad is associated with Sidem Pharma, a company that focuses on pharmaceutical innovations. His work at Sidem Pharma has allowed him to explore and develop new chemical compounds that can lead to advancements in medication.

Collaborations

Throughout his career, Stéphane has collaborated with notable professionals in the field, including Avraham Cohen and François Schutze. These collaborations have contributed to the success of his research and the development of his patented inventions.

Conclusion

Stéphane Bernad is a distinguished inventor whose work on tenatoprazole potassium salts showcases his expertise in pharmaceutical chemistry. His contributions have the potential to enhance the effectiveness of pharmaceutical compositions, marking him as a significant figure in the industry.